<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04324463</url>
  </required_header>
  <id_info>
    <org_study_id>PHRI.ACT.COVID19</org_study_id>
    <nct_id>NCT04324463</nct_id>
  </id_info>
  <brief_title>Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial</brief_title>
  <acronym>ACTCOVID19</acronym>
  <official_title>Anti-Coronavirus Therapies to Prevent Progression of COVID-19, a Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Population Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Population Health Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      ACT is a randomized clinical trial to assess therapies to reduce the clinical progression of&#xD;
      COVID-19.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ACT COVID-19 program consists of two parallel trials testing the effects of interventions&#xD;
      in complementary populations in outpatients and inpatients.&#xD;
&#xD;
      In the outpatient study, symptomatic patients in the community who are COVID-19 positive and&#xD;
      at high risk of disease progression: colchicine compared with control (anti-inflammatory);&#xD;
      and ASA compared with control (anti-thrombotic); using a 2 x 2 factorial design. The primary&#xD;
      outcome for colchicine vs. control is the composite of hospitalization or death; and the&#xD;
      co-primary outcome is disease progression by 2 points on a 7-point scale. The primary outcome&#xD;
      for ASA vs. control is the composite of hospitalization or death; and the co-primary outcomes&#xD;
      are the composite of major adverse cardiovascular events (MI, stroke, ALI, VTE, death), and&#xD;
      disease progression by 2 points on a 7-point scale.&#xD;
&#xD;
      For inpatients, in symptomatic patients who are COVID-19 positive and who are hospitalized:&#xD;
      colchicine is compared with control (anti-inflammatory), and the combination of ASA and&#xD;
      rivaroxaban is compared with control (anti-thrombotic); using a 2 x 2 factorial design. The&#xD;
      primary outcome for colchicine vs. control is the composite of invasive mechanical&#xD;
      ventilation or death, and the co-primary outcome is disease progression by 2 points on a&#xD;
      7-point scale. The primary outcome for the combination of ASA and rivaroxaban vs. control is&#xD;
      the composite of invasive mechanical ventilation or death; and the co-primary outcomes are&#xD;
      the composite of major adverse cardiovascular events (MI, stroke, ALI, VTE, death) and&#xD;
      disease progression by 2 points on a 7-point scale.&#xD;
&#xD;
      *The Inpatient study previously also included a comparison of Interferon-β with control in a&#xD;
      2x2x2 design. The Interferon-β arm was closed to recruitment in November 2020.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Open-label, parallel group, factorial, randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Outpatient trial - Colchicine vs. control; Aspirin vs. control</measure>
    <time_frame>45 days post randomization</time_frame>
    <description>composite of hospitalization or death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Outpatient trial - Colchicine vs. control; Aspirin vs. control</measure>
    <time_frame>45 days post randomization</time_frame>
    <description>disease progression of 2 points on a 7 point Scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Outpatient trial - Aspirin vs. control</measure>
    <time_frame>45 days post randomization</time_frame>
    <description>composite of major adverse cardiovascular events (myocardial infarction [MI], stroke, acute limb ischemia [ALI], VTE, death)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inpatient trial - Colchicine vs. control; Aspirin and rivaroxaban vs. control</measure>
    <time_frame>45 days post randomization</time_frame>
    <description>composite of invasive mechanical ventilation or death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inpatient trial - Colchicine vs. control; Aspirin and rivaroxaban vs. control</measure>
    <time_frame>45 days post randomization</time_frame>
    <description>disease progression of 2 points on a 7 point Scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inpatient trial - Aspirin and rivaroxaban vs. control</measure>
    <time_frame>45 days post randomization</time_frame>
    <description>composite of major adverse cardiovascular events (myocardial infarction [MI], stroke, acute limb ischemia [ALI], VTE, death)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Outpatient trial</measure>
    <time_frame>45 days post randomization</time_frame>
    <description>Death, admission to hospital, invasive mechanical ventilation, admission to intensive care unit (ICU), renal replacement therapy, ECMO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inpatient trial</measure>
    <time_frame>45 days post randomization</time_frame>
    <description>Invasive mechanical ventilation, death, admission to (ICU), renal replacement therapy, ECMO</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Coronavirus</condition>
  <condition>Severe Acute Respiratory Syndrome</condition>
  <arm_group>
    <arm_group_label>Colchicine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Outpatients:&#xD;
0.6 mg twice daily for 3 days, then 0.6 mg once daily for 25 days (total 28 days).&#xD;
Inpatients:&#xD;
1.2 mg followed by 0.6 mg 2 hours later, then 0.6 mg twice daily for 28 days.&#xD;
(*Depending on availability, 0.6 mg tablets can be substituted by 0.5 mg tablets for a regimen in outpatients of 0.5 mg twice daily for 3 days, then 0.5 mg once daily for 25 days [total 28 days]; and in inpatients of 1.0 mg followed by 0.5 mg 2 hours later, then 0.5 mg twice daily for 28 days).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Interferon Beta [This arm is now closed to recruitment]</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inpatients Only:&#xD;
0.25 mg by subcutaneous injection on days 1, 3, 5 &amp; 7</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspirin (ASA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Outpatients:&#xD;
75 to 100 mg once daily for 28 days.&#xD;
Inpatients:&#xD;
75 to 100 mg once daily for 28 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rivaroxaban</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inpatients Only:&#xD;
2.5 mg twice daily for 28 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care (Control)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Outpatients and Inpatients: No constraints for treating physicians on the therapies within the standard of care arm. All key co-interventions will be documented.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colchicine</intervention_name>
    <description>oral medication</description>
    <arm_group_label>Colchicine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Interferon-Beta</intervention_name>
    <description>subcutaneous injection</description>
    <arm_group_label>Interferon Beta [This arm is now closed to recruitment]</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin</intervention_name>
    <description>oral medication</description>
    <arm_group_label>Aspirin (ASA)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rivaroxaban</intervention_name>
    <description>oral medication</description>
    <arm_group_label>Rivaroxaban</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Outpatient trial:&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          1. Symptomatic and laboratory-confirmed diagnosis of COVID-19.&#xD;
&#xD;
          2. Age ≥18 years.&#xD;
&#xD;
          3. High risk: either age ≥70 or one of the following: male; obesity (BMI ≥30); chronic&#xD;
             cardiovascular, respiratory or renal disease; active cancer; diabetes.&#xD;
&#xD;
          4. Within 7 days (ideally 72 hours) of diagnosis, or worsening clinically.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. General: advanced kidney disease; advanced liver disease; pregnancy (known or&#xD;
             potential) or lactation.&#xD;
&#xD;
          2. Colchicine: allergy or planned use; current or planned use of cyclosporine, verapamil,&#xD;
             HIV protease inhibitor, azole antifungal, or macrolide antibiotic (except&#xD;
             azithromycin).&#xD;
&#xD;
          3. ASA: allergy; high risk of bleeding, current or planned use of other anti-thrombotic&#xD;
             drugs (e.g., P2Y12 inhibitors, direct oral anticoagulants, vitamin K antagonists,&#xD;
             heparins)&#xD;
&#xD;
        Inpatient trial:&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          1. Symptomatic and laboratory-confirmed diagnosis of COVID-19.&#xD;
&#xD;
          2. Age ≥18 years.&#xD;
&#xD;
          3. Within 72 hours (ideally 24 hours) of admission, or worsening clinically.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. General: advanced kidney disease; advanced liver disease, pregnancy (known or&#xD;
             potential) or lactation, already ventilated for &gt;72 hours.&#xD;
&#xD;
          2. Colchicine: allergy or planned use; current or planned use of cyclosporine, verapamil,&#xD;
             HIV protease inhibitors, azole antifungals, or macrolide antibiotics (except&#xD;
             azithromycin).&#xD;
&#xD;
          3. ASA and rivaroxaban: allergy; high risk of bleeding; estimated GFR &lt;15 ml/min; current&#xD;
             or planned use of P2Y12 inhibitors or therapeutic doses of anticoagulants* (e.g.,&#xD;
             direct oral anticoagulants, vitamin K antagonists, heparin, LMWH), current or planned&#xD;
             use of strong inhibitors of both CYP 3A4 and P-gp (e.g., lopinavir/ritonavir,&#xD;
             carbamazepine, ketoconazole). *Note that prophylactic doses of anticoagulants can be&#xD;
             used in patients who are randomized to control.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Whitlock, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Population Health Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emilie Belley-Cote, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Population Health Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Eikelboom, MBBS MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Population Health Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ACT COVID-19 Study Coordinator</last_name>
    <phone>905-297-3479</phone>
    <email>ACT.ProjectTeam@PHRI.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Adventista de Manaus</name>
      <address>
        <city>Manaus</city>
        <state>Amazonas</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Prodal Saude S/A</name>
      <address>
        <city>Salvador</city>
        <state>BA</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital das Clinicas de Vitoria (Hospital Universitario Cassiano Antonio Moraes)</name>
      <address>
        <city>Vitoria</city>
        <state>ES</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ubermed Serviços em Saúde Eireli - Hospital São Domingos</name>
      <address>
        <city>Uberaba</city>
        <state>MG</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital de Clínicas da Universidade Federal de Uberlândia</name>
      <address>
        <city>Uberlândia</city>
        <state>MG</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Julio Muller</name>
      <address>
        <city>Cuiabá</city>
        <state>Mount</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario da UFPI - Filial EBSERH</name>
      <address>
        <city>Teresina</city>
        <state>PI</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Gaffree e Guinle</name>
      <address>
        <city>Rio de Janeiro</city>
        <state>RJ</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Prof. Dr. Horacio Carlos Panepucci da Universidade Federal de Sao Carlos (HU-UFSCar)</name>
      <address>
        <city>São Carlos</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Alemão Oswaldo Cruz</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ACT COVID-19 Study Coordinator</last_name>
      <email>ACT@PHRI.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Southlake Regional Health Centre</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Halton Healthcare/Oakville Trafalgar Memorial Hospital</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Niagara Health System-St. Catharine's</name>
      <address>
        <city>St. Catharines</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Toronto Western Hospital Family Health Team</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Windsor Regional Hospital</name>
      <address>
        <city>Windsor</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Woodstock Hospital</name>
      <address>
        <city>Woodstock</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CIUSSS de L'est-de-l'ile de Montreal, Hopital Maisonneuve-Rosemont</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de l'Université de Montréal (CHUM)</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Biomelab SAS</name>
      <address>
        <city>Barranquilla</city>
        <state>Atlantico</state>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinica de la Costa LTDA</name>
      <address>
        <city>Barranquilla</city>
        <state>Atlantico</state>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instituto de Neumologico del Oriente</name>
      <address>
        <city>Bucaramanga</city>
        <state>Santander</state>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Unicormed</name>
      <address>
        <city>Guayaquil</city>
        <state>Guayas</state>
        <country>Ecuador</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital de Especialidades Eugenio Espejo</name>
      <address>
        <city>Quito</city>
        <state>Pichincha</state>
        <country>Ecuador</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Enrique Garces</name>
      <address>
        <city>Quito</city>
        <state>Pichincha</state>
        <country>Ecuador</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital General Pablo Arturo Suarez</name>
      <address>
        <city>Quito</city>
        <state>Pichincha</state>
        <country>Ecuador</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Giza Chest Hospital</name>
      <address>
        <city>Giza</city>
        <state>Cairo</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Abbasia Chest Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Abbasia Fever Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Hepatology and Tropical Medicine Research Institute</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fayoum University Hospital</name>
      <address>
        <city>Fayoum</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CIMS Hospital</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>City Plus Hospital</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sanjivani Hospital</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>GMERS Medical College &amp; Hospital</name>
      <address>
        <city>Vadodara</city>
        <state>Gujarat</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Post Graduate Institute of Medical Sciences (PGIMS)</name>
      <address>
        <city>Rohtak</city>
        <state>Haryana</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mazumdar Shaw Medical Centre a Unit of Narayana</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bharathi Hospital and Research Center</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sidhu Hospital Pvt.Ltd</name>
      <address>
        <city>Doraha</city>
        <state>Punjab</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Vijaya Medical &amp; Educational Trust</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>SRM Institute of Science and Technology</name>
      <address>
        <city>Kattankulathur</city>
        <state>Tamil Nadu</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>AIG Hospital</name>
      <address>
        <city>Hyderabad</city>
        <state>Telangana</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>KIMS</name>
      <address>
        <city>Hyderabad</city>
        <state>Telangana</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mahavir Hospital &amp; Research Centre</name>
      <address>
        <city>Hyderabad</city>
        <state>Telangana</state>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Aga Khan University Hospital</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jinnah Postgraduate Medical Center</name>
      <address>
        <city>Karachi</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tabba Heart Institute</name>
      <address>
        <city>Karachi</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Philippine General Hospital</name>
      <address>
        <city>Manila</city>
        <state>Metro Manila</state>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Budgetary Health Care Institution of Sverdlovsk region &quot;Central city clinical hospital # 6 Ekaterinburg&quot;</name>
      <address>
        <city>Ekaterinburg</city>
        <state>Sverdlovsk Region</state>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Central City Clinical Hospital No. 24</name>
      <address>
        <city>Yekaterinburg</city>
        <state>Sverdlovsk Region</state>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Voronezh State Medical University named after N.N. Burdenko</name>
      <address>
        <city>Voronezh</city>
        <state>Voronezh Region</state>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Altai Regional Hospital for War Veterans</name>
      <address>
        <city>Barnaul</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Medical Research Center for Therapy and Preventive Medicine</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital No. 3</name>
      <address>
        <city>Nizhny Novgorod</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rostov State Medical University</name>
      <address>
        <city>Rostov-on-Don</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>King Saud Medical City</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Thumbay Hospital Dubai</name>
      <address>
        <city>Al Qusais</city>
        <state>Dubai</state>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hatta Hospital</name>
      <address>
        <city>Hatta</city>
        <state>Dubai</state>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rashid Hospital, Dubai Health Authority</name>
      <address>
        <city>Umm Hurair</city>
        <state>Dubai</state>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Colombia</country>
    <country>Ecuador</country>
    <country>Egypt</country>
    <country>India</country>
    <country>Pakistan</country>
    <country>Philippines</country>
    <country>Russian Federation</country>
    <country>Saudi Arabia</country>
    <country>United Arab Emirates</country>
  </location_countries>
  <removed_countries>
    <country>Chile</country>
  </removed_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 25, 2020</study_first_submitted>
  <study_first_submitted_qc>March 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2020</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>coronavirus</keyword>
  <keyword>interferon</keyword>
  <keyword>colchicine</keyword>
  <keyword>aspirin</keyword>
  <keyword>rivaroxaban</keyword>
  <keyword>anti-inflammatory</keyword>
  <keyword>antithrombotic</keyword>
  <keyword>anti-viral</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Interferons</mesh_term>
    <mesh_term>Interferon-beta</mesh_term>
    <mesh_term>Colchicine</mesh_term>
    <mesh_term>Rivaroxaban</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

